69 Views | 16 Downloads
Annapaola Mariniello, annapaola.mariniello@unito.it
Conceptualization, S.N., M.G., P.B., A.M. and F.T.; methodology, A.M., F.T. and M.G.; software and formal analysis, A.M., M.G.; investigation, D.I., A.M., F.T., M.T., N.A.R., L.R., M.G., E.C., S.C., V.B., C.M., F.P. and P.B.; resources, S.N., P.B. and M.G.; data curation, D.I., M.G., M.T., N.A.R., A.M. and F.T. writing—original draft preparation, A.M.; writing—review and editing, F.T., D.I., M.T., N.A.R., M.L.R., A.L., E.C., S.C., V.B., C.M., L.C., M.D.F., M.B., C.P., M.D.M., F.P., L.R., D.S., S.N., M.G. and P.B.; visualization, F.T., D.I., M.T., N.A.R., M.L.R., A.L., E.C., S.C., V.B., C.M., L.C., M.D.F., M.B., C.P., M.D.M., F.P., L.R., D.S., S.N., M.G. and P.B.; supervision, D.S., M.D.M., S.N., M.G. and P.B.; project administration, S.N., P.B., M.G.; funding acquisition, S.N., P.B. All authors have read and agreed to the published version of the manuscript.
Di Maio M declares advisory board/personal fees from AstraZeneca, Boehringer Ingelheim, Janssen, Merck Serono, Merck Sharp & Dohme, Novartis, Roche, Takeda, Pfizer, Beigene, Tesaro. Reale ML declares advisory board/speaker bureau per Eli Lilly, AstraZeneca, MSD. Passiglia F declares consultant/advisory from Amgen, Janssen, Astra Zeneca, Beigene, MSD, Thermo Fisher Scientific. Novello S reports personal payment or honoraria for lectures, presentations, speaker’s bureaus, manuscript writing, or educational events from Abbvie, AstraZeneca, BeiGene, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, Pfizer, Pharmamar, Roche, and Takeda; and personal fees for participation on a data safety monitoring board or advisory board from AstraZeneca, Bayer, Daiichi Sanko, Eli Lilly, Pfizer, Roche, Sanofi, and Takeda. The remaining authors do not declare conflicts of interest.
© 2022 by the authors.